Activating mutations in ALK provide a therapeutic target in neuroblastoma. George, RE , Sanda T. , Hanna M. , Fröhling S. , Luther W 2nd , Zhang J. , Ahn Y. , Zhou W. , London WB , McGrady P. , Xue L. , Zozulya S. , Gregor VE , Webb TR , Gray NS , Gilliland DG , Diller L. , Greulich H. , Morris SW , Meyerson M. , et al. Nature, 2008/10/16, Volume 455, Issue 7215, p.975-8, (2008)
Read More / View Supplemental Materials
Share This
(function(d, s, id) {
var js, fjs = d.getElementsByTagName(s)[0];
if (d.getElementById(id)) return;
js = d.createElement(s); js.id = id;
js.src = "//connect.facebook.net/en_US/all.js#xfbml=1";
fjs.parentNode.insertBefore(js, fjs);
}(document, 'script', 'facebook-jssdk'));
!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0];if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src="//platform.twitter.com/widgets.js";fjs.parentNode.insertBefore(js,fjs);}}(document,"script","twitter-wjs");
(function() {
var po = document.createElement('script'); po.type = 'text/javascript'; po.async = true;
po.src = 'https://apis.google.com/js/plusone.js';
var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(po, s);
})();
Abstract